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The aim of this study is to describe premature microbubbles destruction with contrast-enhanced voiding urosonography (ce-
VUS) in children using 2nd-generation ultrasound contrast agents (UCA) and to hypothesize about the reason. 141 children (61
females and 80 males) were included in the study, with mean age of 3.3 years (range 4 weeks–16.0 years), who underwent ce-VUS
examination between 2011 and 2014. Premature destruction of themicrobubbles in the urinary bladder during ce-VUSwas observed
in 11 children (7.8%). In all these cases the voiding phase of ce-VUS examination could not be performed because of destroyed
UCA microbubbles. This was noted in anxious, crying infants and children with restricted voiding. The premature destruction of
ultrasound contrast agent during ce-VUS is an underreported, important limitation of ce-VUS, which prevents evaluation of the
voiding phase and the establishment of vesicoureteric reflux (VUR). This was particularly noted in crying infants and children.
1. Introduction
Contrast-enhanced voiding urosonography (ce-VUS) is the
most common application of second-generation ultrasound
contrast agents (UCA) in children [1].The ce-VUS is generally
considered as a promising tool with high accuracy to diag-
nose vesicoureteric reflux (VUR), comparable to standard
voiding cystourethrography (VCUG) [2–4]. Some technical
limitations concerning visualization of the urethra in ce-
VUS have now been mastered [5, 6]. Administration of the
microbubbles is in general well tolerated, and the so far
reported side effects weremainly linked to the catheterization
procedure [1, 7, 8]. To the best of our knowledge, there are
no published reports about difficulties that may arise in the
case of premature intravesical destruction of microbubbles.
In this post hoc analysis, we describe a series of patients in
whom this problem occurred and analyzed the mechanisms
possibly responsible for this phenomenon.
2. Material and Methods
2.1. Subjects. Between January 1st, 2011, and December, 31st,
2014, 141 children (61 girls and 80 boys) with the mean age of
3.3 years (range 4 weeks–16.0 years) underwent ce-VUS and
were consequently enrolled to the prospective study accord-
ing to the protocol. From the study cohort, we performed a
post hoc analysis based on the selected children with reports
of premature microbubbles destruction and control group
of children with fully diagnostic ce-VUS. The control group
was sex- and age-matched to the group of children with
premature microbubbles destruction (28 children; 11 girls, 17
boys; mean age 2.0 years, range 4 weeks–11.0 years). As far
as experiences concerning the use of the second-generation
UCA in contrast-enhanced voiding urosonography are still
limited, all information about the duration of bladder filling,
first symptoms of destruction and subtotal/total destruction
or any side effects and possible technical problems like crying,
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problems with voiding, and so forth were collected in study
reports of all cases.
2.2. Examination. All examinations were performed without
sedation. The indication for the examination was in all
situationsmade by the treating pediatrician. Indications were
as follows: urinary tract infection, diagnosed in ultrasound
dilatation of the urinary excretory system after nephrologist
consultation, follow-up of VUR, and neurogenic bladder.
A baseline gray-scale US and ce-VUS examination of the
urinary tract were both performed in the supine and prone
positions. All US examinations were performed using an
Aloka 𝛼6 device (Aloka, Hitachi-Aloka Medical, Ltd., Japan),
using 5.0–8.0MHz convex and 8.0–12.0MHz linear probes;
however, ce-VUS was done only with the convex probe.
During ce-VUS examination, the mechanical index (MI)
was between 0.06 and 0.08. The position of the transducer
was continuously altered during the ce-VUS examinations
to avoid excessive exposure to insonization and destroying
microbubbles in one region. All examinations were recorded
on digital video clips. In the case of restriction during the
voiding phase, short video clips were recorded every 60–90
seconds to prevent microbubbles excessive destruction.
All childrenwere under prophylactic antibiotic therapy in
accordance with the nephrologist’s recommendation.
Patients were catheterized transurethral under aseptic
conditions with a 4 F–14 F feeding tube (Bicakcilar, Turkey)
after its lubrication with lidocaine hydrochloride anesthetic
gel (Lignocainum U (2%), Jelfa, Poland). After catheteriza-
tion, the bladder was completely emptied. A plastic bottle
containing a mixture of 0.9% NaCl (Solution of sodium
chloride 0.9%, Jelfa, Poland) and sulphur hexafluoride
(SonoVue, Bracco, Milan, Italy) (see below) was connected
through the drip system to the catheter and placed about
80 cm above the examination table. The total volume of
the bladder was estimated with the Koff formula: volume
in milliliters = (age in years + 2) × 30 [9]. The filling of
the bladder was continued until the child started to feel
the urge to void, the calculated volume was reached, or the
dripping speed of the infusion fluid slowed down due to back
pressure. With the child in the supine position, both kidneys,
the bladder, and the lower ureter were scanned alternately
during continued filling andwhile voiding using the contrast-
enhanced ultrasound option. The catheter was removed
before voiding. Additionally, during the voiding phase the
urethra was examined. In the case of total microbubbles
destruction, we had to skip the voiding phase and discontinue
the examination.
2.3. SonoVue Preparation. Three different lots of sulphur
hexafluoride were used.
During one examination session, two up to five children
were examined.Theperiod between reconstitution of sulphur
hexafluoride and the last examination was never longer than
4 hours.The contrast agent (sulphur hexafluoride, SonoVue)
was dissolved in saline (sodium chloride 0.9%, Jelfa, Poland)
shortly before each exam under aseptic conditions. In all
cases a total of 0.5–1.0mL of sulphur hexafluoride was added
to a 100–250mL 0.9% saline solution in a plastic bottle)
(prewarmed to 32∘) with the use of 2mL luer-lock type
syringe and 18G needle. Before administration, the mixture
was gently shaken until it appeared homogenous. When the
expected urinary bladder volume was greater than 250mL,
an additional bottle of the solution was prepared.
2.4. Elimination Potential Factors ofMicrobubbles Destruction.
To find an explanation for the premature destruction of
microbubbles, all possible causes linked to technical aspects
of ce-VUS examination were excluded, including a wide
range of operator depending factors which could influence
on ce-VUS imaging [10, 11]. To ce-VUS examination, we use
only low-frequency probes (convex) with dedicated settings
and MI 0.07–0.1. The linear probe was used only at the
beginning of the examination to scan the kidneys in b-
mode option, but not after contrast administration. The
probe was never kept in the same position longer than
few seconds. The focus zone was always set in the lowest
position. The examinations were performed and analyzed by
two experienced physicians. No erroneous composition of
the SonoVue solution as a potential source of the problemwas
identified. During every examination session, on average four
children received a solution from the same vial of SonoVue
and the premature destruction of microbubbles was never
observed in more than one child per session. The order
of the patients with this phenomenon in each session was
casual. Premature destruction of microbubbles occurred in
two children who received the microbubbles first, in three
children who received the microbubbles as second, in three
children who received as third, in twowho received as fourth,
and in one child who received as fifth.
The microbubbles due to the high impedance difference
backscattered the ultrasound wave at the surface and cre-
ated a detectable signal. Observed in our study loss of the
microbubbles signal in urine bladder could have different
reasons. Among others, microbubbles could be destroyed
during preparation the solution of saline and microbub-
bles, too low microbubbles level in solution, and unsuitable
insonation power during the examination. However, we paid
special attention to the procedure of contrast preparation
and technic of examination. In all cases with premature
microbubble destruction, in the initial phase of examination
signal from contrast filling urinary bladder was always
satisfactory and fully diagnostic. In all cases, weakening of
signal was observed in the course of the examination.
2.5. Definitions. Restricted voiding was defined as a period of
at least 10 minutes after the removal of the catheter without
effective voiding.
Premature destruction of microbubbles was defined as
destruction of microbubbles before the voiding phase, lead-
ing to the total vanishing of the microbubbles and precluding
evaluation of VUR during the ce-VUS voiding phase.
3. Results
In the study group, there were no observed side effects after
intravesical application of the UCA. In our study, the number
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Table 1: Group of children with destruction of the microbubbles in the urinary bladder during ce-VUS examination.
Number Sex Age (yearsmonths)
ce-VUS Reflux
Right Kidney
ce-VUS Reflux
Left Kidney
Urinary bladder
max voiding vol.
(mL)
T1 (min) T2 (min) T3 (min)
Anxiety (A); crying
(C); multiple
voiding attempts (V)
1 M 9 y 3m F-G0; V-N/A F-G0; V-N/A 260 2 4 14 V
2 F 7 y 2m F-G0; V-N/A F-G0; V-N/A 190 10 12 16 V
3 M 1 y 9m F-GI; V-N/A F-G0; V-N/A 100 6 6 20 A; C
4 M 2 y 8m F-G0; V-N/A F-G0; V-N/A 130 4 5 11 A; C
5 M 8 y 1m F-GIII; V-N/A F-GII; V-N/A 300 4 6 12 V
6 M 11m F-GIV; V-N/A F-GIV; V-N/A 50 5 5 8 A; C
7 M 2 y F-GIII; V-N/A F-GIV; V-N/A 70 4 6 22 A; C
8 F 6m F-G0; V-N/A F-G0; V-N/A 50 2 4 9 A; C
9 M 2 y 2m F-GII; N/A F-GIII; N/A 100 3 3 16 A; C
10 F 4m F-GIII; N/A F-GII; N/A 40 2 4 10 A; C
11 F 1 y 5m F-G0; V-N/A F-G0; V-N/A 90 3 4 8 A; C
Sex = female (F) and male (M).
Reflux Right Kidney = filling phase (F); voiding phase (V); Grades I–V (GI–V); no reflux (G0); not possible to estimate due to destruction of microbubbles
(N/A).
Reflux LeftKidney = filling phase (F); voiding phase (V), Grades I–V (GI–V), no reflux (G0); not possible to estimate due to destruction ofmicrobubbles (N/A).
T1: time of the urinary bladder filling.
T2: first symptoms of destruction.
T3: subtotal/total destruction.
of side effects due to the procedure did not differ significantly
from data reported in medical literature and were similar to
traditional VCUG.
A total of 11 cases (7.8%) presented premature destruction
of the microbubbles in the urinary bladder (Table 1). None
of these children had a neurogenic urinary bladder or other
urinary bladder abnormalities.
In the case of three older children (numbers 1, 2, and 5
(Table 1)) the destruction of the microbubbles started 2 or
more minutes after complete filling of the urinary bladder
and after a few attempts of unproductive voiding (Figures
1(a)–1(d)). All three had the restriction of voiding (likely
due to psychogenic stress). The elapsed time to voiding
varied from 30 to 45 minutes. Due to earlier destruction of
microbubbles (total destruction noticed between 10 and 16
minutes of examination), the assessment of the voiding phase
was impossible, and the examination was discontinued.
Eight younger children and infants (Table 1) also pre-
sented restricted voiding; all of them were anxious and cried
without interruption during the entire examination. In this
group, the destruction of microbubbles had been noticeable
at the end of the urinary bladder filling phase (Figures 2(a)–
2(e)). Hence, in three cases (numbers 3, 6, and 9 (Table 1))
an additional dose of saline and contrast solution was
administrated before removal of the catheter, but this effort
did not resolve the problem and microbubbles continued to
be destroyed before the voiding phase. Details concerning
the duration of bladder filling and total examination time
for cases and controls are given in Table 2. No differences
in bladder filling times were seen between the two groups.
As expected, total examination time was longer in cases.
However, destruction of microbubbles occurred on average
five minutes after completion of the bladder filling in the
Table 2: Technical details concerning ce-VUS (results are given as
median (min–max) values).
Cases Controls
𝑁 11 28
Age 2.1 (4m–9 y) 2.0 (1m–11 y)
Sex (% female) 36.4 39.3
Bladder filling time (min) 4.0 (2–10) 4.0 (0.50–5)
Total examination time (min) 12.0 (8–22) 5.50 (4.30–10)
Destruction of microbubbles (min) 5.0 (4–12) —
cases, which was within the duration of the total examination
time in controls. The evaluation of the voiding phase in all
cases of premature contrast destructionwas impossible due to
the absence of an echo signal from themicrobubbles (Figures
3(a) and 3(b)) (Table 1). In cases with vesicoureteric reflux, we
observed that in some of them signal in refluxing ureter was
strong as at the beginning of the examination, while at the
same time weakening of signal due to contrast microbubble
destruction in the bladder was evident like in Figure 4.
4. Discussion
Taken together, the results of this monocentric case study
suggest that, in 11/141 patients (7.8%), ce-VUS could not be
completed due to the premature destruction of themicrobub-
bles. The premature destruction of microbubbles occurred
especially in anxious, constantly crying children and in
children with restricted voiding and precluded assessing
voiding phase during ce-VUS. Consequently, it could have a
major impact on the clinical outcome in the case of the ce-
VUS procedure.
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Figure 1: Subject 2: seven-year-old girl. (a) Filling the urinary bladder (white long arrows) with the contrast agent. (b) Urinary bladder
(white long arrows) 2 minutes after removal of the catheter and two failed voiding attempts, beginning of microbubbles destruction. (c)
Urine bladder (white long arrows) 5 minutes after removal of the catheter with visible areas of destructed microbubbles (short white arrows).
(d) Urinary bladder (white long arrows) 6minutes after removal of the catheter andmultiple voiding attempts, with visible single echoes from
not destroyed microbubbles (short white arrows).
Therefore, a better understanding of the pathophysiology
of this phenomenon is urgently needed.
Destruction of microbubbles occurred on average five
minutes after bladder filling. Since this was within the average
total examination time of the controls, the destruction of
microbubbles cannot simply be ascribed to the longer dura-
tion of the examination. None of the controls showed signs
of destruction of microbubbles, although their examination
time was sometimes up to 2.5 times longer than the destruc-
tion time of microbubbles in the case group.
The duration of VUS including the catheterization time
and precontrast imaging in our study was approximately
15–20min. In previous studies, the mean examination time
for ce-VUS was between 8 and 34 minutes, depending on
the contrast product and ultrasound modality used [4, 6,
12, 13]. Hence, the phenomenon of premature microbubble
destruction cannot be explained by a longer examination
time in our centre as compared to other groups. Finally, there
were no significant differences in age or sex between cases and
controls, excluding the possibility of age- or sex-related effect.
The observation that premature destruction occurred in
anxious, constantly crying children with prolonged restric-
tion of voiding led us to consider that physical factors might
play a role. Hence, it is well known that the “lifetime” and
destruction of contrast particles depends on numerous phys-
ical factors such as acoustic pressure, hydrostatic pressure,
liquid temperature, and the amount of dissolved gas in
the ambiance of microbubbles [14–16]. The different factors
determining the disappearance time of gas bubbles are given
by the equation of Epstein and Plesset, further adapted by de
Jong et al. [14, 17]:
𝑑𝑅
𝑑𝑡 = 𝐷𝐿(
𝐶
𝑖
/𝐶
𝑜
− 1 − 2𝜎/𝑅𝑃
𝑜
− 𝑝ov/𝑃𝑜
1 + 4𝜎/3𝑅𝑃
𝑜
)
⋅ ( 1𝑅 +
1
√𝜋𝐷𝑡) ,
(1)
where 𝑅 is radius of the bubbles, 𝑇 is time, 𝐷 is diffusion
constant, 𝐶
𝑖
/𝐶
𝑜
is ratio of the dissolved gas concentration
to the saturation concentration, 𝜎 is surface tension, 𝑃
𝑜
is ambient pressure, 𝐿 is Ostwald coefficient, and 𝑝ov is
overpressure.
This equation shows that the gas bubbles disappear more
quickly when they are exposed to overpressure (bolded in
the equation). In the case of intravenous administration
in clinical practice, an overpressure of microbubbles takes
place in two different situations: during their injection (over-
pressure in the syringe and the needle) and while in the
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(e)
Figure 2: Subject 6: 11-month-old boy, high anxiety and constantly crying during the examination. (a) Filling the urinary bladder (white
long arrows) with the contrast agent. (b) Urinary bladder (white long arrows) a few seconds after removal of the catheter, beginning of the
microbubbles destruction. (c) Urinary bladder (white long arrows) 1 minute after removal of the catheter. (d) Urinary bladder (white long
arrows) 2 minutes after removal of the catheter, with visible areas of absent echoes due to destroyed microbubbles (short white arrows).
Urinary bladder (white long arrows) 3 minutes after removal of the catheter with visible single echoes from not destroyed microbubbles
(short white arrows).
arteries of systemic circulation (systolic blood pressure). As
shown by Talu et al., the destruction of perfluorocarbon-filled
microbubbles depends on the needle size and injection flow
rate [18].
de Jong et al. observed that albumin bubbles tend to
shrink and disappear if a hydrostatic pressure of 20 kPa
(203.9 cmH
2
O) is applied [14, 19]. Vuille et al. reported that
the disappearance time of shelled UCA microbubbles was
two, three, and nine times shorter when exposed to pressures
of, respectively, 6 kPa (61.2 cmH
2
O), 13 kPa (132.6 cmH
2
O),
or 19 kPa (193.7 cmH
2
O) [20].
In vitro experiments suggest that shelled microbub-
bles have a high resistance to hydrostatic pressure up to
600mmHg (815.7 cmH
2
O) [16]. However, in vivo studies
have illustrated that additional forces such as local shear and
forces generated by the transducer acoustic pressure also act
on microbubbles and shorten their disappearance time [21].
In the urinary bladder, the intravesical pressure is the sum
of pressure induced by detrusor contractions together with
the intra-abdominal pressure. The maximum intravesical
pressure during voiding recorded by a transurethral catheter
in infants and children with no apparent voiding symptoms
ranges from 56.6 ± 20.3 cmH
2
O in infants <1 yr to 70.7 ±
13.6 cmH
2
O in 12-year-old children [22]. In another study
using suprapubic catheters, intravesical pressure and voiding
detrusor pressures varied between 107 and 117 cmH
2
O in
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Figure 3: Subject 5: 8-year-1-month-old boy. (a) Urinary bladder (white long arrows) during filling phase. Visible dilated ureter with refluxing
microbubbles (red short arrows). (b) Urinary bladder (white long arrows) with single persistent microbubbles of contrast agent 6 minutes
after the end of the filling phase (short white arrows). Visible dilated ureter with single refluxing microbubbles (red short arrows).
Figure 4: Higher signal of refluxing left ureter than of the urinary
bladder, where microbubbles destruction started.
infants (3–10 months old); pressures were around 75 cmH
2
O
in girls [23]. In infants with lower tract urinary dysfunction
characterized by high voiding pressure levels, low bladder
capacity, and dyscoordination at voiding, VUR is com-
mon with an estimated prevalence around 80% [24]. In
infants with known VUR, voiding detrusor pressures ranged
between 75 and 234 cmH
2
O in a study by Sille´n at al. and
180 cmH
2
O in a study by Chandra and Maddix [24, 25].
The overpressure inside the urinary bladder is potentially
a very important factor influencing the disappearance time
of gas bubbles. Constant crying and prolonged restriction
of voiding are likely to increase, respectively, the abdominal
and intravesical pressure. In accordance with the equation
of Epstein and Plesset, further adapted by de Jong et al. (see
above), the higher the overpressure acting on the microbub-
bles in the urinary bladder, the faster their destruction. High
hydrostatic pressure might be the mechanism responsible for
the premature destruction of microbubbles. However, in this
post hoc analysis, intravesical and intra-abdominal pressures
were not measured; more research is therefore needed to
explore further this pathway.
This post hoc analysis has several other limitations. No
datawere acquired on the composition of the urine on the day
of the exam, although the presence of microscopic hematuria
or the osmolality might have played a role in the premature
destruction of microbubbles.
Besides, data concerning behavior was not available in all
examined children. We have prospectively analyzed behavior
during voiding urosonography in another group of 35 chil-
dren undergoing VCUG. We noticed anxiety and crying in
4/16 (25%) of children under 1 years old, in 5/11 (45%) of
children between 1 and 4 years, and 1/8 (12%) of children over
4 years old. In none of them, the premature destruction of
microbubbles occurred. These percentages were thus largely
inferior to the one observed in our cases and strengthen (but
not prove) our hypothesis that crying plays a role.
The authors performed another study (in press) compar-
ing classical VCUG and ce-VUS. The agreement between the
ce-VUS and VCUG in the diagnosis or exclusion of the VUR
reached more than 95% (personal communication). In 7/84
cases, the diagnosis with the ce-VUS was impossible to be set
due to damagingmicrobubbles of contrast; two children were
continuously crying while in five cases there were problems
with getting voiding phase (personal communication). The
frequency of microbubbles destruction was comparable in
both studies (personal communication).
5. Conclusions
We describe for the first time the presence of premature
microbubble destruction in ce-VUS, with an estimated preva-
lence of 7.8%. As it was post hoc analysis study more
epidemiological data are necessary to estimate its prevalence
in different populations and countries. According to our
assumptions, constantly crying infants and children with
restriction during the voiding phase are at risk, probably
due to pressure-related mechanisms, and should be under
careful observation during the ce-VUS examination. Further
research is needed to disentangle themechanisms responsible
for this phenomenon.
All values of the pressure were converted in this text to
the unit of cmH
2
O accordingly to the equations as below:
10-millimeter mercury (0∘C) = 13.595434809-centi-
meter water (4∘C).
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10-millimeter mercury (0∘C) = 13.3322 hectopascals.
10-centimeter water (4∘C) = 9.80638 hectopascals.
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